Full Length Research Paper
References
|
Cappellini MD, Fiorelli G (2008). Glucose 6-phosphate dehydrogenase deficiency. Lancet 371:64-74. |
|
|
Cavalli-Sforza LL, Menozzi P, Piazza A (1994). The history and geography of human genes. Princeton University Press. Princeton. N.J. |
|
|
Earnest B, Stephen D (2007). G6PD deficiency and anti-malaria drug development. American Journal of Tropical Medicine and Hygiene 77(4)779-789. |
|
|
Frank JE (2005). Diagnosis and management of G6PD deficiency. American Family Physician 72(7):1277-1282. |
|
|
Ginsburg H, Golenser J (1999). Redox metabolism in G-6-P dehydrogenase deficient erythrocytes and its relation to anti-malaria chemotherapy. Parasitologia 41(1-3):309-311. |
|
|
Gomez-Manzo S, Marcial-QuinoJ, Ortega-Cuellar D, Serrano-Posada H, Gonzalez-Valdez A, Vanoye-Carlo A, Hernandez-Ochoa B, Sierra-Palacios E, Castillo-Villanueve A, Reyes-Vivas H (2017). Functional and biochemical analysis of glucose 6-phosphate dehydrogenase (G6PD) variants: elucidating the molecular basis of G6PD deficiency. Catalysis 7:135. |
|
|
Guindo A, Fairhust RM, Doumbo OK, Wellems TE, Diallo DA (2007). X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Medicine 4(3):e66. |
|
|
Howes RE, Piel FB, Patil AP, Nvangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI (2012).G6PD deficiency prevalence estimates of affected populations in malaria endemic countries; a geostatistical model-based map. PLos Medicine 9;e1001339 |
|
|
Howes RE, Dewi M, Piel FB, Monterio WM, Battle KE, Messina JP, Sakuntabhi A, Satyagraha AW, Williams TN, Baird JK, Hay SI (2013). Spatial distributionof G6PD deficiency variants across malaria-endemic regions. Malaria Journal 12:418. |
|
|
Luzzatto L, Nannelli C, Notaro R (2016). Glucose 6-phosphate dehydrogenase deficiency. Hematology/Oncology Clinics 30(2):373-393. |
|
|
Pathak V, Colar R, Ghosh K (2018). Effect of inherited red cell defects on growth of Plasmodium falciparum; An in-vitro study. The Indian Journal of Medical Research 147:102-109. |
|
|
Recht J, Ashley EA, White NJ (2018). Use of primaquine and glucose 6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries. PLoS Neglected Tropical Diseases 12(4): e0006230. |
|
|
Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbolds CT, Greenwood BM, Marsh K, Hill AVS (1995). Natural selection of hemi- and heterozygotes for G-6-PD deficiency in Africa by resistance to severe malaria. Nature 376:246-249. |
|
|
Rich SM, Licht MC, Hudson RR, Ayala FJ (1998). Malarias Eve: evidence of a recent population bottleneck throughout the world populations of Plasmodium falciparum. Proceedings of the National Academy of Science USA 95:4425-4430. |
|
|
Volkman AK, Barry AI, Lyons EJ, Nielsen KM, Thomas SM, Choi M, Thakore SS, Day KP, Whirth DF, Hartl DI (2001). Recent origin of Plasmodium falciparum from a single progenitor. Science 293:484. |
|
|
World Health Organization (WHO) (2019). Updating the WHO G6PD classification of variants and the International classification of Diseases, 11 Revision (ICD-11). Malaria Policy Committee Meeting. Background document for session 7. October 2-4: Geneva. Switzerland. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
